SMARCB1 and urinary bladder carcinoma: Study have demonstrated that absence of SMARCB1 (encoding SNF5/BAF47 protein) leads to enhanced chromatin accessibility at the STAT3 promoter, which in turn triggers activation of the IL6/JAK/STAT3 pathway to facilitate the growth and spread of bladder cancer [23].